The purpose of this research study is to evaluate the effectiveness of the study product on vasomotor symptoms (VMS) and overall menopause symptoms in healthy women, who are perimenopausal or postmenopausal, and aged 40 - 65.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To determine the effects of the Study Product (SP) compared to placebo on hot flash symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on hot flash symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on hot flash symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on vasomotor symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on overall menopausal symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on overall menopausal symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on quality of life
Timeframe: 12 weeks